MassMutual Private Wealth & Trust’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
ISL
PA
MassMutual Private Wealth & Trust's CORT Position: Q2 2026 in Review
MassMutual Private Wealth & Trust reduced its Corcept Therapeutics (CORT) stake by 17% in Q2 2026, selling an estimated $5.19K and leaving 432 shares worth $37.6K. The position accounts for ﹤0.01% of the portfolio, ranked #885.
MassMutual Private Wealth & Trust first reported a position in CORT in Q1 2018 and has held it in 17 quarters since. The position peaked at $140K in Q4 2023. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.
- MassMutual Private Wealth & Trust held 432 shares of Corcept Therapeutics worth $37.6K as of Q2 2026.
- MassMutual Private Wealth & Trust sold 86 Corcept Therapeutics shares in Q2 2026, an estimated $5.19K.
- Corcept Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #885 holding.
- MassMutual Private Wealth & Trust first reported a position in Corcept Therapeutics in Q1 2018 and has held it in 17 quarters since.
- MassMutual Private Wealth & Trust's Corcept Therapeutics position peaked at $140K in Q4 2023.
- 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.
Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.